(Q35066124)

6 August 2017

1 reference

title

Glucagon-like peptide 2 function in domestic animals (English)

1 reference

6 August 2017

D G Burrin

1

1 reference

PubMed ID

12586312

6 August 2017

B Stoll

series ordinal

2

1 reference

PubMed ID

12586312

6 August 2017

X Guan

series ordinal

3

1 reference

6 August 2017

1 March 2003

1 reference

6 August 2017

20

1 reference

Domestic Animal Endocrinology

inferred from page(s)

published in

1 reference

6 August 2017

24

1 reference

6 August 2017

2

1 reference

6 August 2017

103-122

1 reference

The glucagon-like peptides

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagon antibodies and their use for immunoassay for glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Distribution of immunoassayable glucagon in gastrointestinal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Molecular Size of Extractable Glucagon and Glucagon-like Immunoreactivity (GLI) in Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Immunofluorescent localization of secretin and enteroglucagon in human intestinal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Hamster preproglucagon contains the sequence of glucagon and two related peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Exon duplication and divergence in the human preproglucagon gene

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Evidence that glicentin contains the entire sequence of glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagon-Like Peptides GLP-1 and GLP-2, Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas*

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Response of plasma and tissue levels of enteroglucagon immunoreactivity to intestinal resection, lactation and hyperphagia

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Ileal glucagon gene expression: ontogeny and response to massive small bowel resection

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Nutrient-independent increases in proglucagon and ornithine decarboxylase messenger RNAs after jejunoileal resection

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Intestinal adaptation

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Intestinal proliferation and delayed intestinal transit in a patient with a GLP-1-, GLP-2- and PYY-producing neuroendocrine carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagonoma syndrome demonstrating giant duodenal villi

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Biological actions and therapeutic potential of the glucagon-like peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Gut adaptation and the glucagon-like peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Molecular evolution of proglucagon.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Immunofluorescent localization of enteroglucagon cells in the gastrointestinal tract of the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: An immunohistochemical and immunochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Identification and localization of glucagon-related peptides in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

The proglucagon gene upstream enhancer contains positive and negative domains important for tissue-specific proglucagon gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Alpha-cell-specific expression of the glucagon gene is conferred to the glucagon promoter element by the interactions of DNA-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Foxa3 (HNF-3gamma) binds to and activates the rat proglucagon gene promoter but is not essential for proglucagon gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

POU domain transcription factor brain 4 confers pancreatic alpha-cell-specific expression of the proglucagon gene through interaction with a novel proximal promoter G1 element

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

The LIM domain homeobox gene isl-1 is a positive regulator of islet cell-specific proglucagon gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

A physiological level of rhubarb fiber increases proglucagon gene expression and modulates intestinal glucose uptake in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Systemic short-chain fatty acids rapidly alter gastrointestinal structure, function, and expression of early response genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Transcriptional regulation of genes encoding insulin, glucagon, and angiotensinogen by sodium butyrate in a rat islet cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Short-chain fatty acids and total parenteral nutrition affect intestinal gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Proteolytic processing in the secretory pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Proglucagon Processing Profile in Canine L Cells Expressing Endogenous Prohormone Convertase 1/3 and Prohormone Convertase 2

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Role of prohormone convertases in the tissue-specific processing of proglucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Structure, measurement, and secretion of human glucagon-like peptide-2

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Fetal rat intestinal cells in monolayer culture: a new in vitro system to study the glucagon-like immunoreactive peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Metabolic responses to enteral and parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Metabolic and endocrine consequences of depriving preterm infants of enteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Plasma glucagon-like peptide-1 (7-36) amide (GLP-1) response to liquid phase, solid phase, and meals of differing lipid composition

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Secretion of trophic gut peptides is not different in bolus- and continuously fed piglets

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

GIP and GLP-1(7-36)amide secretion in response to intraduodenal infusions of nutrients in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Relationship between molecular structures of sugars and their ability to stimulate the release of glucagon-like peptide-1 from canine ileal loops

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Fermentable carbohydrates elevate plasma enteroglucagon but high viscosity is also necessary to stimulate small bowel mucosal cell proliferation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

The evolving role of alpha-glucosidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Human gut hormone profiles in patients with short bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Hyperenteroglucagonaemia and small intestinal mucosal growth after colonic perfusion of glucose in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Regulation of Intestinal Proglucagon- Derived Peptide Secretion by Intestinal Regulatory Peptides*

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Stimulatory effect of beta-adrenergic agonists on ileal L cell secretion and modulation by alpha-adrenergic activation

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Regulation of glucagon-like peptide-1-(7-36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Plasma and intestinal concentrations of GIP and GLP-1 (7-36) amide during suckling and after weaning in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Dipeptidyl Peptidase IV Inhibition Enhances the Intestinotrophic Effect of Glucagon-Like Peptide-2 in Rats and Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Structural determinants for activity of glucagon-like peptide-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

The Inhibitory Effect of Glucagon-Like Peptide-1 (7-36)amide on Antral Motility is Antagonized by Its N-Terminally Truncated Primary Metabolite GLP-1 (9-36)amide

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Renal catabolism of human glucagon-like peptides 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagonlike peptide-2 enhances small intestinal absorptive function and mucosal mass in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Proglucagon-derived peptides in intestinal epithelial proliferation: glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagon-Like Peptide-2 Inhibits Centrally Induced Antral Motility in Pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Effect of glucagon, glicentin, glucagon-like peptide-1 and -2 on interdigestive gastroduodenal motility in dogs with a vagally denervated gastric pouch

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Effect of peptide YY on gastric, pancreatic, and biliary function in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagon-like peptide-1(7-36) amide is a new incretin/enterogastrone candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Plasma Enteroglucagon after Jejunoileal Bypass with 3:1 or 1:3 Jejunoileal Ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Systemic GLP-2 levels do not limit adaptation after distal intestinal resection

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal--jejunal transposition or small bowel resection

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Effect of parenteral nutrition supplemented with short-chain fatty acids on adaptation to massive small bowel resection

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Hormonal therapy for short bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Distinctive effects of glicentin, GLP-1 and GLP-2 on adaptive response to massive distal small intestine resection in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Short-term Administration of Glucagon-like Peptide-2. Effects on Bone Mineral Density and Markers of Bone Turnover in Short-Bowel Patients with No Colon

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Deficiency of the intestinal growth factor, glucagon-like peptide 2, in the colon of SCID mice with inflammatory bowel disease induced by transplantation of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Release of vasodilator, but not vasoconstrictor, neuropeptides and of enteroglucagon by intestinal ischaemia/reperfusion in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagonlike peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Maintaining gut integrity during parenteral nutrition of tumor-bearing rats: effects of glucagon-like peptide 2

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Enteroendocrine localization of GLP-2 receptor expression in humans and rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagon-like peptide containing pathways in the regulation of feeding behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagon-like peptide 2 stimulates intestinal epithelial proliferation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Signaling mechanisms of glucagon-like peptide 2-induced intestinal epithelial cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected 125I-GLP-2

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Modulation of specific intestinal epithelial progenitors by enteric neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0739-7240%2802%2900210-2

7 January 2021

10.1016/S0739-7240(02)00210-2

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12586312